In a rapidly evolving job market shaped by artificial intelligence, Ryan Roslansky emphasizes that technical expertise alone won’t guarantee success. Instead, he highlights five critical human skills that AI cannot replicate: curiosity, compassion, communication, courage, and creativity. These “soft” skills are becoming increasingly essential as AI takes over routine tasks, leaving humans to focus on areas that require emotional intelligence, original thinking, and strong interpersonal connections.

Life sciences business owners and leaders stepping into executive roles often discover that results stall for reasons that have nothing to do with science. The core tension is simple: high-stakes work depends on cross-functional collaboration, yet corporate communication barriers turn decisions into delays, handoffs into rework, and accountability into finger-pointing. These collaboration challenges show up most in growing teams and diverse hiring pipelines, where misalignment quietly undermines performance and career momentum. Strengthening teamwork creates faster alignment, clearer ownership, and better outcomes.

The CNBC article explains that LinkedIn’s 2026 “Skills on the Rise” report highlights how the U.S. job market is shifting toward a skills-first economy, where what workers can do matters more than their degrees or job titles. Driven largely by rapid advances in artificial intelligence, employers are prioritizing practical, demonstrable abilities—what the article calls “career currency.” The report is based on data tracking both how frequently skills are added to profiles and how often they appear among newly hired candidates, reflecting real hiring demand.

The U.S. Food and Drug Administration (FDA) has issued new draft guidance aimed at accelerating the development of biosimilar drugs and expanding access to more affordable biologic treatments. The guidance would streamline clinical pharmacokinetic (PK) testing and allow developers to reduce or eliminate certain studies when supported by strong scientific evidence. These changes could significantly lower development costs—potentially reducing PK study expenses by up to 50%, or about $20 million per biosimilar.

Many companies are turning to “peanut butter” pay raises — giving the same modest increase to all employees rather than rewarding individual performance. This trend, highlighted in a recent CNBC report, stems from organizations trying to manage tight budgets and simplify compensation. Experts warn this approach may backfire: by spreading raises evenly irrespective of contribution, employers risk demotivatin

Merck reorganizes ahead of looming Keytruda patent cliff — Facing the anticipated loss of U.S. exclusivity for its blockbuster cancer drug Keytruda, Merck & Co. is splitting its human health business into two focused units: a standalone oncology division and a separate specialty, pharma & infectious diseases unit.

Life sciences executives and HR professionals often feel squeezed between urgent hiring goals, tighter budgets, and growing expectations to show credible sustainability leadership. At the same time, many teams still treat environmental impact at work as a facilities issue or a corporate report, leaving everyday decisions disconnected from measurable responsibility.

Award-winning author Charles Duhigg says that the candidates who shine in job interviews aren’t just the most qualified - they’re the best communicators. By showing authenticity, listening with empathy, and using thoughtful storytelling, you not only answer questions but build real connection and trust. These simple habits make you a more compelling candidate and transform interviews into meaningful conversations.

Teva Pharmaceuticals has enlisted actor and comedian Will Forte to help amplify its Honestly HD Huntington’s disease awareness campaign. Forte, best known for his work on Saturday Night Live, shares a personal perspective working alongside his brother-in-law Doug Modling, who lives with Huntington’s, in new campaign content that highlights the challenges of the disease and the support available to those affected.

In a recent CNBC Make It article, career expert Amanda Augustine highlights three key red flags candidates should watch for during interviews that could signal a toxic or poorly run workplace. These include situations where the hiring team can’t clearly define the role, interviewers avoid answering tough questions, or the overall tone and environment feel tense or unprofessional.

AbbVie has struck a new drug pricing agreement with the White House that aligns with the administration’s most-favored-nation pricing initiative. Under the deal, the company will lower prices on select medicines for Medicaid and expand direct-to-patient offerings through the TrumpRx platform, while committing to $100 billion in U.S. research, development and capital investment over the next decade.

Being labeled “overqualified” can feel like a setback, but career experts say it’s often a soft rejection rather than a reflection of your ability. The key is to own your story—explain why you’re genuinely interested in the role, how your experience aligns with the company’s needs, and that you see long-term value in the position. Experts emphasize reframing your background as an asset and addressing potential employer concerns about fit, commitment, and career goals.

The U.S. Food and Drug Administration has approved a daily oral version of the popular weight-loss drug Wegovy, marking a major milestone in obesity treatment. This first-of-its-kind GLP-1 weight-loss pill from Novo Nordisk contains the same active ingredient, semaglutide, found in the injectable Wegovy and Ozempic, and is expected to expand access to those who prefer a pill over injections.

The U.S. Food and Drug Administration has approved AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu (fam-trastuzumab deruxtecan) in combination with Roche’s Perjeta as a first-line treatment for adults with unresectable or metastatic HER2-positive breast cancer confirmed by an FDA-approved test.

Experts are warning users not to share sensitive information with ChatGPT and other AI chatbots because the data you type can be stored, analyzed, and used to improve models — and may not remain private. The key categories of information you should avoid sharing include personally identifiable details (name, address, IDs), intimate personal life details, medical and health information, confidential work or proprietary business data, and financial information like bank or credit card details.

UCB announced that it will move forward with regulatory submissions for Fintepla® (fenfluramine) as a treatment for seizures associated with CDKL5 Deficiency Disorder (CDD), following highly positive results from its Phase 3 clinical trial. This represents a potential third indication for Fintepla, which is already approved for Dravet syndrome and Lennox-Gastaut syndrome.

In today’s fast-moving business environment, investing in staff training is no longer optional — it’s a competitive necessity. Whether your team needs sharper technical skills, stronger leadership, or better communication across borders, the right learning programs can unlock growth and resilience.

As Gen Z returns to the office in growing numbers, they’re not just filling the physical space — they’re transforming it. According to a CNBC article, this generation is leaning into authenticity, mental health, and digital fluency, bringing new energy to work environments older generations may no longer frequent. From candid check-ins on well-being, to dressing casually and speaking in their own voice, to fully embracing AI tools as collaborators — Gen Z is reshaping corporate norms on its own terms.

Regeneron is investing $2 billion to convert a former Quad Graphics magazine printing plant in Saratoga Springs, New York, into a drug-manufacturing facility, part of its broader push to onshore more of its production.

In this article, Adam Grant, a Wharton psychologist, argues that to identify the best candidates in an interview, hiring teams should focus on two main actions:

1. Ask what really matters for growth and contribution.